SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jean Bao, Nicholas Borja, Madhu Rao, James Huth, A. Marilyn Leitch, Aeisha Rivers, Rachel Wooldridge, Roshni Rao, Impact of weight change during neoadjuvant chemotherapy on pathologic response in triple-negative breast cancer, Cancer Medicine, 2015, 4, 4
  2. 2
    Ulla Arthur Hvidtfeldt, Anne Tjønneland, Niels Keiding, Theis Lange, Ingelise Andersen, Thorkild I. A. Sørensen, Eva Prescott, Åse Marie Hansen, Morten Grønbæk, Stig Egil Bojesen, Finn Diderichsen, Naja Hulvej Rod, Risk of Breast Cancer in Relation to Combined Effects of Hormone Therapy, Body Mass Index, and Alcohol Use, by Hormone-receptor Status, Epidemiology, 2015, 26, 3, 353

    CrossRef

  3. 3
    M. F. Munsell, B. L. Sprague, D. A. Berry, G. Chisholm, A. Trentham-Dietz, Body Mass Index and Breast Cancer Risk According to Postmenopausal Estrogen-Progestin Use and Hormone Receptor Status, Epidemiologic Reviews, 2014, 36, 1, 114

    CrossRef

  4. 4
    Nicoletta Biglia, Elisa Peano, Paola Sgandurra, Giulia Moggio, Silvia Pecchio, Furio Maggiorotto, Piero Sismondi, Body mass index (BMI) and breast cancer: impact on tumor histopatologic features, cancer subtypes and recurrence rate in pre and postmenopausal women, Gynecological Endocrinology, 2013, 29, 3, 263

    CrossRef

  5. 5
    Leena Hilakivi-Clarke, Sonia de Assis, Anni Warri, Exposures to Synthetic Estrogens at Different Times During the Life, and Their Effect on Breast Cancer Risk, Journal of Mammary Gland Biology and Neoplasia, 2013, 18, 1, 25

    CrossRef

  6. 6
    Nicole R. Stendell-Hollis, Patricia A. Thompson, Cynthia A. Thomson, Mary J. O’Sullivan, Roberta M. Ray, Rowan T. Chlebowski, Investigating the Association of Lactation History and Postmenopausal Breast Cancer Risk in the Women's Health Initiative, Nutrition and Cancer, 2013, 65, 7, 969

    CrossRef

  7. 7
    S. J. Nyante, C. M. Dallal, G. L. Gierach, Y. Park, A. R. Hollenbeck, L. A. Brinton, Risk Factors for Specific Histopathological Types of Postmenopausal Breast Cancer in the NIH-AARP Diet and Health Study, American Journal of Epidemiology, 2013, 178, 3, 359

    CrossRef

  8. 8
    Kim Robien, Cheryl L. Rock, Wendy Demark-Wahnefried, Nutrition in the Prevention and Treatment of Disease, 2013,

    CrossRef

  9. 9
    B. J. Fuhrman, C. Schairer, M. H. Gail, J. Boyd-Morin, X. Xu, L. Y. Sue, S. S. Buys, C. Isaacs, L. K. Keefer, T. D. Veenstra, C. D. Berg, R. N. Hoover, R. G. Ziegler, Estrogen Metabolism and Risk of Breast Cancer in Postmenopausal Women, JNCI Journal of the National Cancer Institute, 2012, 104, 4, 326

    CrossRef

  10. 10
    A Zeleniuch-Jacquotte, R E Shore, Y Afanasyeva, A Lukanova, S Sieri, K L Koenig, A Idahl, V Krogh, M Liu, N Ohlson, P Muti, A A Arslan, P Lenner, F Berrino, G Hallmans, P Toniolo, E Lundin, Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancer, British Journal of Cancer, 2011, 105, 9, 1458

    CrossRef

  11. 11
    Susan R. Sturgeon, Stella L. Volpe, Elaine Puleo, Elizabeth R. Bertone-Johnson, Joanna Heersink, Sara Sabelawski, Kristina Wähälä, Carol Bigelow, Mindy S. Kurzer, Effect of Flaxseed Consumption on Urinary Levels of Estrogen Metabolites in Postmenopausal Women, Nutrition and Cancer, 2010, 62, 2, 175

    CrossRef

  12. 12
    Erin F. Gillespie, Melony E. Sorbero, David A. Hanauer, Michael S. Sabel, Emily J. Herrmann, Laura J. Weiser, Christina H. Jagielski, Jennifer J. Griggs, Obesity and Angiolymphatic Invasion in Primary Breast Cancer, Annals of Surgical Oncology, 2010, 17, 3, 752

    CrossRef

  13. 13
    Dominik Rachoń, Helena Teede, Ovarian function and obesity—Interrelationship, impact on women's reproductive lifespan and treatment options, Molecular and Cellular Endocrinology, 2010, 316, 2, 172

    CrossRef

  14. 14
    Cher Dallal, Emanuela Taioli, Urinary 2/16 estrogen metabolite ratio levels in healthy women: A review of the literature, Mutation Research/Reviews in Mutation Research, 2010, 705, 2, 154

    CrossRef

  15. 15
    Michael F. Leitzmann, Corinna Koebnick, Kim N. Danforth, Louise A. Brinton, Steven C. Moore, Albert R. Hollenbeck, Arthur Schatzkin, James V. Lacey, Body mass index and risk of ovarian cancer, Cancer, 2009, 115, 4
  16. 16
    Michael Wacker, Betsy Risendal, Kim Westerlind, Dennis Lezotte, Tim Byers, Ethnicity, Body Size, and Estrogen Levels in Postmenopausal Hispanic and Non-Hispanic White Women, Journal of Women's Health, 2009, 18, 4, 487

    CrossRef

  17. 17
    A. Im, V. G. Vogel, G. Ahrendt, S. Lloyd, C. Ragin, S. Garte, E. Taioli, Urinary estrogen metabolites in women at high risk for breast cancer, Carcinogenesis, 2009, 30, 9, 1532

    CrossRef

  18. 18
    M.N.G. Dukes, 2009,

    CrossRef

  19. 19
    Jennie Wang, ChunYang, Euphemia Wang, Shihong Li, Nurulain Zaveri, Paul Liu, Chromatographic analysis and decomposition product characterization of compound SR16157 (NSC 732011), Journal of Pharmaceutical and Biomedical Analysis, 2007, 45, 4, 572

    CrossRef

  20. 20
    T.L. Klug, E. Bågeman, C. Ingvar, C. Rose, H. Jernström, Moderate coffee and alcohol consumption improves the estrogen metabolite profile in adjuvant treated breast cancer patients: A pilot study comparing pre- and post-operative levels, Molecular Genetics and Metabolism, 2006, 89, 4, 381

    CrossRef